Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aurinia Pharmaceuticals Inc

AUPH
Current price
5.74 USD +0.19 USD (+3.42%)
Last closed 5.85 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 846 015 296 USD
Yield for 12 month -27.43 %
1Y
3Y
5Y
10Y
15Y
AUPH
21.11.2021 - 28.11.2021

Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States. It offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was incorporated in 1993 and is headquartered in Edmonton, Canada. Address: 118 Avenue , 14315, Edmonton, BC, Canada, T5L 4S6

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

11.86 USD

P/E ratio

Dividend Yield

Current Year

+158 533 000 USD

Last Year

+134 030 000 USD

Current Quarter

+42 315 000 USD

Last Quarter

+54 515 000 USD

Current Year

+144 385 000 USD

Last Year

+128 366 000 USD

Current Quarter

+36 920 000 USD

Last Quarter

+47 746 000 USD

Key Figures AUPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -74 144 000 USD
Operating Margin TTM -52.72 %
PE Ratio
Return On Assets TTM -10.52 %
PEG Ratio
Return On Equity TTM -19.92 %
Wall Street Target Price 11.86 USD
Revenue TTM 175 512 992 USD
Book Value 2.63 USD
Revenue Per Share TTM 1.23 USD
Dividend Share
Quarterly Revenue Growth YOY 58.6 %
Dividend Yield
Gross Profit TTM 83 378 000 USD
Earnings Share -0.54 USD
Diluted Eps TTM -0.54 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin -44.45 %

Dividend Analytics AUPH

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AUPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 23.10.2013
Dividend Date

Stock Valuation AUPH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 1428.5714
Enterprise Value Revenue 5.6558
Price Sales TTM 4.8202
Enterprise Value EBITDA -12.3107
Price Book MRQ 2.917

Financials AUPH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AUPH

For 52 weeks

5.5 USD 12.43 USD
50 Day MA 8.32 USD
Shares Short Prior Month 16 387 511
200 Day MA 9.07 USD
Short Ratio 8.4
Shares Short 18 529 600
Short Percent 12.95 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

402.79 USD Microsoft Corporation -0.45 (-0.11%)
Detailed analytics

ETF funds


S

SX7EEX

11.59 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2031.07 USD Gold +9.2 (+0.46%)
Detailed analytics